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POSTTRAUMATIC EPILEPSY
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What animal models tell us about the process and
treatment options
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lar and cellular alterations corresponding to the
immediate and early phases of PTE, chronic studies relevant to the epileptogenesis phase are
sparse. Moreover, despite the multiple preclinical
pharmacologic and cell therapy trials, there is no
information available describing whether these
therapeutic approaches aimed at improving posttraumatic recovery would also affect the development of lowered seizure threshold and epilepsy.
To make progress, there is an obvious need for
information exchange between the trauma and
epilepsy fields. In addition, the inclusion of epilepsy
as an outcome measure in preclinical trials aiming
at improving somatomotor and cognitive recovery after TBI would provide valuable information
about possible new avenues for antiepileptogenic
interventions and disease modification after TBI.
KEY WORDS: Antiepileptic drug, Epileptogenesis, Fluid-percussion injury, Recovery, Surrogate
marker.

SUMMARY
A large number of animal models of traumatic
brain injury (TBI) are already available for studies
on mechanisms and experimental treatments of
TBI. Immediate and early seizures have been
described in many of these models with focal or
mixed type (both gray and white matter damage)
injury. Recent long-term video-electroencephalography (EEG) monitoring studies have
demonstrated that TBI produced by lateral
fluid-percussion injury in rats results in the development of late seizures, that is, epilepsy. These
animals develop hippocampal alterations that are
well described in status epilepticus–induced spontaneous seizure models and human posttraumatic
epilepsy (PTE). In addition, these rats have damage ipsilaterally in the cortical injury site and thalamus. Although studies in the trauma field provide
a large amount of information about the molecu-

mechanical force to the head occurring at the time of
injury (primary TBI, Table 1), or those that result from
nonmechanically induced secondary complications that
were or were not initiated by the primary damage (secondary TBI, Table 1). The extent and distribution of damage
can vary from focal to diffuse, comprising a variety of different types of lesions (Table 1). Mechanisms of damage
can vary from the direct impact to the skull/brain (e.g., a
fall) to the acceleration/deceleration type of injury (e.g.,
rapid head rotation in a car accident) (Table 1). This variability challenges not only modelers of TBI, but in particular those who wish to develop models for posttraumatic
epilepsy (PTE). This relates to the fact that information
about the risk factors for PTE originates mostly from retrospective epidemiologic studies rather than prospective

Heterogeneity of TBI in
Humans—A Challenge for
Animal Model Development
Traumatic brain injury (TBI) in humans is a heterogeneous disorder that can differ in the type of injury, distribution of damage, or mechanisms of damage (Gennarelli
& Graham, 2005). Regarding the type of injury, TBI can
be classified into those injuries that result from a direct
Address correspondence to Dr. Asla Pitknen, A. I. Virtanen Institute
for Molecular Sciences, University of Kuopio, PO Box 1627, FIN-70211
Kuopio, Finland. E-mail: asla.pitkanen@uku.fi
Wiley Periodicals, Inc.
ª 2009 International League Against Epilepsy

21

22
A. Pitkänen et al.
Table 1. Classification of traumatic brain injury,
type of damage, and mechanisms of damage
according to Gennarelli and Graham (2005)
Traumatic brain injury
Primary
Injury to scalp
Skull fracture
Surface contusion/laceration
Intracranial hematoma
Diffuse axonal injury
Diffuse vascular injury
Injury to cranial nerves and pituitary stalk
Secondary
Hypoxia–ischemia
Swelling/edema
Raised intracranial pressure and associated vascular changes
Meningitis/abscess
Damage after brain injury
Focal
Injury to scalp
Skull fracture
Surface contusion/laceration
Intracranial hematoma
Raised intracranial pressure and associated vascular changes
Diffuse (multifocal)
Diffuse axonal injury
Hypoxic–ischemic damage
Meningitis
Vascular injury
Mechanisms of damage
Contact
Injury to scalp
Fracture of skull with or without an associated extradural hematoma
Surface contusions and lacerations and associated intracerebral
hematomas
Acceleration/deceleration
Tearing of bridging veins with formation of subdural hematoma
Diffuse axonal injury, tissue tears, and associated intracerebral
hematomas
Diffuse vascular injury

studies that would have carefully characterized the details
of injury type, distribution, or the mechanisms of damage
associated with subsequent epileptogenesis using novel
imaging and other methodologies (see Pitknen &
McIntosh, 2006).
Currently available TBI models can be divided into
focal models of TBI, diffuse brain injury models, mixed
models of focal and diffuse brain injury, combined injury
models, experimental models of coma, and models of
repetitive concussive injury (Cernak, 2005; Morales et al.,
2005). Most of these models are performed in rodents and
utilize a direct impact on the epidural space or the brain
tissue (Cernak, 2005). Acceleration models resulting in
widespread white matter damage (diffuse axonal injury,
DAI) have been successfully applied in primates and miniature swine that have a larger amount of white matter than
rodents (Gennarelli et al., 1981; Smith et al., 1997a).
Epilepsia, 50(Suppl. 2):21–29, 2009
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Although none of the TBI models recapitulates fully the
human syndrome, it is well acknowledged that these models are useful for understanding the molecular mechanisms of TBI and testing the efficacy of novel treatments
for TBI (Cernak, 2005; Morales et al., 2005). Therefore,
there are plenty of possibilities when planning to use TBI
models as a starting point for modeling PTE.

Using TBI Models for
Modeling PTE
A PubMed search in April 2008 for the term ‘‘TBI
model’’ yielded approximately 900 references, whereas
the search for the term ‘‘post-traumatic epilepsy model’’
resulted in only around 40 references. In most of these
models, PTE has been triggered by iron injection to the
cortex or the amygdala, or by cortical undercut (Willmore
et al., 1978; see Prince et al., 2009). Only recently, models
developed in the trauma field to investigate human TBI
have been used to assess the development of lowered seizure threshold and epilepsy (Table 2). The large majority
of these studies have used lateral fluid-percussion (LFP)
or central fluid-percussion (CFP) TBI models that produce
both gray matter and white matter damage (Fig. 1). Other
models used include weight drop, controlled cortical
impact, or penetrating ballistic injury models (see Table 2).
All of these models belong to mixed type or focal models
of TBI (Morales et al., 2005).
In Table 2, we have divided the observations made
about the posttraumatic brain excitability into immediate (within 24 h postinjury), early (between 24 h and
1 week postinjury), and late changes (>1 week postinjury) (Frey, 2003). At the immediate phase, a subpopulation of animals that experienced either weight drop
or LFP-induced TBI were reported to experience spontaneous postinjury seizures (Nilsson et al., 1994;
Kharatishvili et al., 2006). In addition, seizure threshold for induced seizures was reduced (Roncati Zanier
et al., 2003) and in vitro studies demonstrated hyperexcitability in the CA1 subfield of the hippocampus
(Reeves et al., 2000; Griesemer & Mautes, 2007). In
addition, during the first week after TBI (early phase,
between 24 h and 1 week postinjury), spontaneous,
presumably injury-related seizures can still occur as
reported by Williams and coworkers in the new penetrating ballistic-like injury (Williams et al., 2005,
2006). At this later phase, most of the in vitro electrophysiologic studies have demonstrated increased excitability not only in the CA1 (Reeves et al., 1997;
Akasu et al., 2002) but also in the dentate gyrus
(Lowenstein et al., 1992; Coulter et al., 1996; Reeves
et al., 1997; Toth et al., 1997; Santhakumar et al.,
2001; Witgen et al., 2005; Tran et al., 2006). In addition to changes in local excitability, Baker et al.
(2002) reported an axonal conductance defect in the

2 days post-TBI

1 week post-TBI

1 week post-TBI
1 week post-TBI

1 week post-TBI
3 h–7 days post-TBI

6–8 days post-TBI

0–72 h

7 days post-TBI

LFP

LFP

LFP
LFP

LFP
CFP

LFP (mice)

Penetrating ballistic-like
injury
LFP (mice)

3 weeks post-TBI

15 weeks post-TBI

Weight drop

Weight drop

LFP
LFP

PTZ kindling started
24 h after TBI
15 days post-TBI
3 months post-TBI

Hippocampal slice

1 week post-TBI
1 week post-TBI

Early phase (£1 week)
LFP
LFP

Late Phase (>1 week)
CFP

In vivo

1 h post-TBI
0–24 h post-TBI
2 h and 24 h post-TBI

LFP
LFP
Weight drop

In vivo
Hippocampal slice

In vivo
Hippocampal - entorhinal
slice
Hippocampal slice

In vivo

Hippocampal slice
Coronal slice with
corpus callosum
Hippocampal slice

Hippocampal slice
Hippocampal slice

Hippocampal slice

In vivo
Hippocampal-entorhinal
slices
In vivo

In vivo
In vivo
Hippocampal slice

In vivo
Hippocampal slice
Hippocampal slice

0–2 h post-TBI
1 h post-TBI
1–4 h post-TBI

Immediate phase (<24 h)
Weight drop
LFP
LFP

Preparation

Postinjury assessment

Injury type

Increased inhibition in dentate gyrus
Decrease in the threshold for generation of self-sustaining epileptiform
activity to high-frequency stimulation in CA1
Bilateral hyperexcitability of the granule cell and molecular layers of dentate
gyrus
Increased susceptibility to PTZ-induced seizures
Bilateral hyperexcitability of the granule cell and molecular layers of dentate
gyrus

No difference in kindling rate as compared to controls

Bilateral dentate gyrus hyperexcitability

Enhanced inhibition in CA1
Reduced inhibition in the dentate gyrus
Seizures in 14% of animals

Increased granule cell hyperexcitability
Increased stimulus-induced afterdischarge duration and self-sustained
epileptic activity in dentate gyrus
Decreased inhibition in CA1
Increased inhibition in dentate gyrus
Decreased feed-forward GABAA receptor-mediated inhibition of granule
cells
Mossy cell and granule cell hyperexcitability
Dentate gyrus hyperexcitability to low-frequency stimulation (recovers in
1 month)
CA1 hyperexcitability
Axonal conductance defect in corpus callosum

82% of rats had electrographic generalized seizures
Increased duration of evoked presynaptic volleys in CA1
Depolarizing shift in the resting membrane potential of dentate
interneurons (recovers in 4 days)
Lowered threshold for kainate-induced behavioral seizures
Up to 30% of rats had behavioral clonic seizures
CA1 pyramidal cell hyperexcitability (not detected in CA3). Normalized
within 3 days

Change in excitability

Table 2. Summary of studies that have investigated changes in brain excitability after traumatic brain injury

Continued

Golarai et al. (2001)

Golarai et al. (2001)

Reeves et al. (1997)
Santhakumar et al. (2001)

Hamm et al. (1995)

Tran et al. (2006)

Williams et al. (2006)

Witgen et al. (2005)

Akasu et al. (2002)
Baker et al. (2002)

Santhakumar et al. (2000)
Santhakumar et al. (2001)

Toth et al. (1997)

Reeves et al. (1997)

Lowenstein et al. (1992)
Coulter et al. (1996)

Roncati Zanier et al. (2003)
Kharatishvili et al. (2006)
Griesemer & Mautes (2007)

Nilsson et al. (1994)
Reeves et al. (2000)
Ross & Soltesz (2000)

Reference
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CCI, controlled cortical impact; CFP, central fluid-percussion traumatic brain injury (TBI); GABA, c-amino butyric acid; LFP, lateral fluid-percussion TBI; P, postnatal day; PTZ,
pentylenetetrazol; rpFPI, rostral parasagittal fluid-percussion injury. All experiments were performed in rats unless otherwise indicated.

D’Ambrosio et al. (2004)
D’Ambrosio et al. (2004)
D’Ambrosio et al. (2005)
Kharatishvili et al. (2006)
Tran et al. (2006)
Kharatishvili et al. (2007)
Statler et al. (2008)
Cortical hyperexcitability
Spontaneous seizures originating in the frontoparietal cortex
Spontaneous hippocampal seizures in addition to cortical seizures
Up to 50% of rats have electrographic seizures clonic seizures
Dentate gyrus hyperexcitability ipsilaterally but not contralaterally
Epileptiform electrographic interictal spiking in 80% of rats
No change in limbic, hindbrain or forebrain seizure threshold
Decreased forebrain (minimal clonic seizure) threshold
Cortical slice
In vivo
In vivo
In vivo
Hippocampal slice
In vivo
In vivo
8–10 weeks post-TBI
2–16 weeks post-TBI
Up to 7 months post-TBI
Up to 1 year post-TBI
30 days post-TBI
Up to 1 year post-TBI
2 weeks post-TBI (P34–40)
6 weeks post-TBI (P60–63)
LFP
LFP
rpFPI
LFP
LFP (mice)
LFP
CCI (P16-18)

Injury type

Postinjury assessment

Preparation

Table 2. Continued

Change in excitability

Reference
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Table 3. Comparison of epilepsy phenotypes in
posttraumatic and post–status epilepticus models

Epilepsy phenotype
Epileptogenesis
Duration of latency
% of rats with seizures
Epilepsy
Mean seizure frequency
Maximal seizure frequency
Mean seizure duration
Day–night cycle
Response to AEDs
Comorbidities
Memory impairment
Sensorimotor impairment
Drug-refractoriness

TBI
Lateral fluid-percussion
Kharatishvili
et al. (2006)

SE
Amygdala
stimulation
Nissinen
et al. (2000)

Several months
50%

Days–1 month
80–100%

0.3/day
Up to 1/day
104 s
44% lights on
No data

8/day
Up to 30/day
49 s
57% lights on
Yes

Yes
Yes
No data

Yes
No data
Yes

AED, antiepileptic drug; SE, status epilepticus; TBI, traumatic
brain injury.

corpus callosum. Whether it has an effect on seizure
spread at later stages remains to be studied.
A survey of conventional animal models in the trauma
field indicates that late spontaneous seizures or epilepsy
have consistently been reported only in the rat fluid-percussion TBI model, which is the most commonly used
model of human closed head TBI (D’Ambrosio et al.,
2004, 2005; Kharatishvili et al., 2006). Interestingly, as
compared to the most commonly used epileptogenesis
models that are induced by status epilepticus (SE), in PTE
induced by LFP injury the epileptogenesis phase is longer,
seizure frequency is substantially lower, and most of the
seizures are secondarily generalized rather than partial
(Table 3; Nissinen et al., 2000; Kharatishvili et al., 2006).
In the rat weight-drop model the threshold for pentylenetetrazol (PTZ)–induced seizures is reduced but no spontaneous seizures have been reported (Golarai et al., 2001).
Recently, Statler et al. (2008) reported lowered minimal
clonic seizure threshold in the mouse controlled cortical
impact (CCI) model. Although reports about the occurrence of spontaneous seizures have been sparse, which
may partly relate to low seizure frequency, observations
available from in vitro slice studies support the idea that
cortical and hippocampal excitability are chronically
increased in a variety of TBI models (Table 2).
There are several caveats to consider when interpreting
the experimental data available. A large majority of the
studies characterizing post-TBI changes in excitability
have investigated rats with focal or mixed type TBI, that
is, models in which white matter damage is not the dominant pathologic feature. This may impose limitations on
data interpretation, in particular when assessing the
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association of type of damage with risk of epileptogenesis
(e.g., focal gray matter damage vs. DAI). In addition, little
information is available about the development of epilepsy in mice with TBI, although such information would
be valuable in guiding the use of genetically modified
mice in search of risk genes for PTE. Furthermore, very
little information is available about the excitability change
after TBI in immature animals, even though childhood
PTE is not uncommon (Statler, 2006). Moreover, combining TBI with other factors such as hypoxia, hyperthermia,
intracerebral bleeding, infection, or SE that compromise
the outcome in the clinical setting could provide useful
information about the mechanisms and conditions that
increase the risk of PTE. We will focus next on the fluidpercussion TBI model, the only model, so far, where the
occurrence of spontaneous seizures has been consistently
demonstrated.

Epileptogenesis versus
Recovery
LFP injury causes both primary and secondary damage
to the brain. The primary damage is caused by the impact
itself, and it initiates ionic, molecular, and cellular alterations within seconds. This is followed by secondary damage that is composed of neurodegeneration, neurogenesis,
astrocytosis, microgliosis, axonal and myelin injury, axonal sprouting, vascular damage, and angiogenesis (see Reilly, 2001; Thompson et al., 2005; Pitknen & McIntosh,
2006). Previous histologic analyses of the LFP injury
model demonstrated that these alterations can happen in
the injured cortex, perifocal area, underlying hippocampus, and/or thalamus (Thompson et al., 2005). Most of the
data concerning the progression of damage have been collected during the first 1–2 months postinjury, which corresponds also to the time period when most of the
electrophysiologic alterations implying increased excitability of injured tissue have been performed (Thompson
et al., 2005). Very few studies have addressed the dynamics of molecular and cellular alterations at the later stages
when the spontaneous seizures appear (Kharatishvili
et al., 2006). The application of MRI in the analysis of cellular and pathway alterations will likely provide useful
information about the association of cellular pathology
with epileptogenesis, and help to understand why epileptogenesis is seen only in a subpopulation of animals
(Kharatishvili et al., 2007).
Well-documented functional consequences of LFPinduced injury include somatomotor and cognitive impairment (Thompson et al., 2005). Interestingly, somatomotor
impairment is partly recoverable within the few weeks or
months postinjury. This is associated with regenerative
cellular processes in the brain such as axonal sprouting
and revascularization. It is important to bear in mind that
epileptogenesis is underway in parallel to the physical

recovery of animals, at least in subpopulations of animals
(Fig. 2).

Preclinical Trials in
Experimental Models of TBI—
Do They Pave the Way for
Finding Antiepileptogenic or
Disease-Modifying Treatments
for PTE?
A large number of different treatments have been
tested to enhance posttraumatic recovery. Pharmacologic
approaches include use of compounds reducing excitotoxicity, calcium channel blockage, free radical scavengers, antiinflammatory agents, neurotrophic factors,
caspase inhibitors, calpain inhibitors, hormonal treatments, augmentation of various neurotransmitter systems,
anticoagulants, poly (ADP-ribose) polymerase (PARP)
inhibitors, and antiepileptic drugs (AEDs) (for a comprehensive review, see Marklund et al., 2006). More
recently, cell transplantation including genetically
manipulated cell types have been tested as a recoveryenhancing treatment option (see Pitknen et al., 2006).
Both in pharmacologic and cell therapy studies, outcome measures have included the effects of treatments on
the edema development, volume of cortical lesions, severity and extent of hippocampal neurodegeneration, axonal
injury, somatomotor function, and learning and memory.
Although positive effects have been obtained in several
experimental trials, treatments have not yet been translated to clinical practice. From the epileptogenesis point
of view it is, however, conspicuous that the development
of late spontaneous seizures has never been an outcome
measure in preclinical TBI trials. This creates a question:
whether some of these treatments were actually antiepileptogenic or disease-modifying, if epilepsy would have
been analyzed as an outcome measure.

Use of AEDs at Early Postinjury
Phase—Any Harm?
As discussed by Temkin (see the present volume), there
is no evidence that any of the AEDs, when administered
after TBI, would have any antiepileptogenic or diseasemodifying effects on the development of PTE in humans.
Conversely: do AEDs compromise the postinjury recovery?
Table 4 summarizes the effects of AEDs on posttraumatic recovery in animal models. So far, remacemide,
topiramate, talampanel, lacosamide, and carisbamate have
been investigated. No major harmful or beneficial effects
have been reported. However, studies in which AEDs had
been administered for a longer period after TBI and in
which outcome measures had been assessed months later
are not available.
Epilepsia, 50(Suppl. 2):21–29, 2009
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Figure 1.
(A) Location of craniectomy in a model of fluid-percussion (FP) traumatic brain injury (TBI) in the two laboratories
that have shown the development of epilepsy in this model of TBI. (B) Injury device that is used for induction of FP
injury. The strength of the injury is adjusted by pendulum height. After release, the pendulum hits the cork piston,
sealing one end of the saline-filled cylinder that transmits the liquid pulse to the epidural space. (C) The injury develops gradually (see also Fig. 2). Here the location and extent of injury is shown in a T2-weighted image (open arrow) at
9 days after lateral FP injury. (D) A thionin-stained coronal section from the brain of a rat subjected to lateral FP
(LFP) brain injury. The animal had been followed for 12 months postinjury and had a total of 11 seizures during seven
video-EEG (electroencephalography) monitoring sessions (63 recording days). The first spontaneous seizure was
recorded 3 months after injury. Seventy-one percent of seizures were secondarily generalized. In addition to the
injury site in the cortex, structural alterations are clear ipsilaterally in the hippocampus (HC) and thalamus (Th). (E)
Higher magnification photomicrograph from a thionin-stained hippocampus from a rat with LFP injury–induced posttraumatic epilepsy (PTE). Note the loss of hilar cells (indicated with an arrow). (F) Timm-stained hippocampal section from the rat with PTE demonstrating mossy fiber sprouting in the inner molecular layer (arrows). CA3, CA3
pyramidal cell layer of the hippocampus; g, granule cell layer; f, the dentate gyrus; H, hilus; m, molecular layer.
Epilepsia ILAE
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Table 4. Effects of administration of antiepileptic drugs on posttraumatic recovery in experimental models
Beginning and duration
of treatment

AED
Remacemide
Topiramate

Talampanel
Lacosamide

Carisbamate (RWJ-333369)

Outcome measures (time of analysis)

Effect

Reference

15 min postinjury
Rx single dose
30 min postinjury
Rx for 32 h

Cortical lesion (48 h postinjury)
Learning and memory (48 h postinjury)
Edema (48 h postinjury)
Neurodegeneration (48 h postinjury)
Memory (48 h postinjury)
Learning (4 weeks postinjury)
Motor recovery (4 weeks postinjury)
Rotating pole (4 weeks postinjury)







æ
æ

Smith et al. (1997b)

30 min postinjury
Rx for 3 day
30 min postinjury
Rx for 3 day

Cortical lesion (7 days postinjury)
CA1 degeneration (7 days postinjury)
Lesion severity (2 weeks postinjury)
Motor function (2 weeks postinjury)
Learning and memory (2 weeks postinjury)
Edema (48 h postinjury)
Lesion size (4 week postinjury)
Motor function (up to 4 week postinjury)
Learning (4 week postinjury)











Belayev et al. (2001)

15 min postinjury
Rx for 1 day

Hoover et al. (2004)

Nissinen et al. (2006)

Keck et al. (2007)

AED, antiepileptic drug.

Figure 2.
The brain faces many challenges after traumatic brain injury (TBI). Acute damage related to the primary impact is followed by a myriad of secondary molecular and cellular changes, including delayed neurodegeneration, neurogenesis,
axonal injury, axonal sprouting, gliosis, and angiogenesis. Many of these alterations are apparently needed for successful recovery that occurs over the weeks and months postinjury. In parallel to the recovery process, a subpopulation of animals undergo epileptogenesis, culminating in the occurrence of spontaneous seizures. The great challenge
is to differentiate those mechanisms that lead to favorable and unfavorable recovery.
Epilepsia ILAE

Future Challenges
We already have plenty of information on postinjury
neurogenesis, synaptogenesis, and revascularization,
which presumably contribute to the repair process. This
raises a question: Is epilepsy a concomitant of an effective
recovery process, a by-product of aberrant recovery, or a
complication that hampers good clinical outcome? Furthermore, would the best recovery enhancements also
modify the epileptogenic process? To find the answers it
will be necessary to differentiate the molecular mechanisms that lead to favorable recovery from those that compromise it. Data available also show that modeling of PTE
is laborious. Therefore, there is an urgent need for devel-

opment of bio/surrogate markers that would predict epileptogenesis after different types of brain injuries and could
be used for selection of animals for studies aimed at understanding the mechanisms of posttraumatic epileptogenesis, preclinical trials testing novel treatments, and also for
the follow-up of treatment efficacy.
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